Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2000 October;66(10) > Minerva Anestesiologica 2000 October;66(10):697-712

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

REVIEWS  CRITICAL AND INTENSIVE THERAPY Free accessfree

Minerva Anestesiologica 2000 October;66(10):697-712

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: Italian

Positive pressure non invasive mechanical ventilation in acute respiratory failure

Scala R.

ASL n. 8 - Arezzo U.O. di Pneumologia


PDF


­Known for two cen­tu­ries, pos­i­tive pres­sure non inva­sive mechan­i­cal ven­ti­la­tion (VMNPP) has ­been wide­ly ­applied in ­acute res­pir­a­to­ry fail­ure (IRA) ­only in the ­last ten ­years. The ­fact ­that ­VMNPP is ­able to ­improve gas ­exchange by avoid­ing endo­tra­cheal intu­ba­tion and its com­pli­ca­tions is the ­most attrac­tive ­aspect in ­both gen­er­al and res­pir­a­to­ry inten­sive ­care ­units and in the res­pir­a­to­ry ­ward. Char­ac­ter­is­tics of ­VMNPP (inter­face, ven­ti­la­tor and modal­ity of ven­ti­la­tion), the ­side ­where it is per­formed as ­well as sever­ity of IRA, under­ly­ing dis­ease, and the ­team’s expe­ri­ence are impor­tant fac­tors ­which influ­ence out­come. The addi­tion of ­VMNPP to con­ven­tion­al med­i­cal ther­a­py reduc­es the ­need for IE, mor­tal­ity and hos­pi­tal­isa­tion in a select­ed pop­u­la­tion of ­BPCO ­patients in IRA. As ­there are no avail­able ­data for com­par­i­son ­between inva­sive mechan­i­cal ven­ti­la­tion (VMI) and ­VMNPP, the lat­ter has not to be con­sid­ered as an alter­na­tive to VMI but ­able to pre­vent it and, ­even if ­VMNPP ­fails, it may be ­used as a wean­ing tech­nique. In IRA due to oth­er ­than ­BPCO dis­eas­es ­VMNPP ­seems not to be ­more effec­tive ­than stan­dard treat­ment in avoid­ing IE but it may ­give effi­cient sup­port ­with few­er com­pli­ca­tions as com­pared to VMI. ­Acute car­di­o­gen­ic pul­mo­nary ede­ma and “ter­mi­nal” dis­eas­es rep­re­sent ­some of the ­most inter­est­ing appli­ca­tion ­fields of ­VMNPP in non-­BPCO ­patients. Accord­ing to the lat­est lit­er­a­ture ­data, in ­this ­review his­to­ry, tech­nique, advan­tag­es, lim­its, indi­ca­tions, nurs­ing and ­cost of ­VMNPP are exam­ined.

top of page